Disclosure: This site earns commissions from affiliate links (Amazon, Etsy, and others) at no extra cost to you.   Full affiliate disclosure →
← ARIA Nurse Finance

ECMO Weaning and Decannulation: Getting the Patient Off the Circuit Safely

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

Part of the ICU Devices Hub — browse every related guide in one place.

This article was created with AI assistance.

Updated July 2026  |  More ICU clinical guides →

Coming off ECMO is not the reverse of going on. It is a deliberate test of whether the native organ has recovered enough to take back its job, followed by a procedure — decannulation — that carries its own bleeding and vascular risks on a still-anticoagulated patient. VV and VA are weaned by different logic and different trials, and the nurse is central to running the trial, reading the response, and owning the surveillance afterward. This guide walks through readiness, how each configuration is weaned, and what happens at and after decannulation.

The short version: Weaning asks whether the native lung (VV) or native heart (VA) has recovered. VV is weaned by turning the sweep gas down/off and seeing if the patient's own lungs handle gas exchange; VA is weaned by reducing flow and watching whether the heart maintains perfusion (guided by echo). Decannulation is a procedure with real bleeding and vascular risk — the nurse owns the pre-trial setup and the post-decannulation surveillance.

Signs the patient may be ready

Before any trial, the team looks for evidence the underlying problem is reversing. On VV, that means improving native lung mechanics and gas exchange: better compliance, a clearing chest X-ray, and the ability to oxygenate and ventilate on modest ventilator settings while ECMO support is already being dialed back. On VA, it means recovering cardiac function: return of arterial pulsatility, improving contractility on echo, decreasing pressor and inotrope needs, and stable perfusion (lactate cleared, good urine output, warm extremities) at lower circuit flows. Weaning is considered when the trajectory is clearly in the right direction, not at the first flicker of improvement.

Weaning VV ECMO: the sweep-off trial

Because VV ECMO supports gas exchange, the wean tests the native lungs by removing the oxygenator's gas exchange while leaving blood flow through the circuit unchanged. The sweep gas is turned down and ultimately off (a "sweep off" or "cap" trial), so the membrane lung stops adding oxygen and removing CO2 while the pump keeps flowing. If the patient's own lungs — on their set ventilator support — maintain acceptable oxygenation and CO2 clearance over the trial period, they have demonstrated they can do the work. Note that flow is usually kept up during the trial to avoid clot from stagnant blood, even though the sweep is off. The nurse monitors saturations, blood gases, work of breathing, and hemodynamics through the trial and reports the response.

Weaning VA ECMO: the flow-reduction trial

VA weaning is fundamentally different because the circuit is providing circulation. You cannot simply cap the gas — you have to hand the circulation back to the heart. So the trial gradually reduces pump flow (to a defined lower limit per protocol, not to zero, because very low flow risks clot) while the team watches with echocardiography whether the heart maintains cardiac output and perfusion. Rising pressor needs, falling blood pressure, echo evidence of poor function, or a climbing lactate at reduced flow means the heart is not ready. Because low flow increases clot risk, VA weaning trials are often kept short and anticoagulation may be adjusted. The nurse is watching the arterial waveform regain pulsatility, the perfusion markers, and the pressor requirement in real time.

VV weaningVA weaning
Tests recovery ofNative lungsNative heart
MethodTurn sweep gas down/off (flow maintained)Reduce pump flow (to a floor, not zero)
Key monitoringABG, SpO2, work of breathing, ventilator supportEcho, MAP, pressor need, lactate, pulsatility
Main risk during trialHypoxemia/hypercarbia if lungs not readyLow-flow clot risk; hemodynamic collapse if heart not ready

Decannulation and its risks

Once a trial succeeds, the cannulas come out. This is a procedure, not a bedside afterthought. Venous cannulas are often removed with direct pressure and a period of firm compression afterward, watching for bleeding and air entrainment (the patient may be asked to hold their breath or be managed to avoid negative intrathoracic pressure at the moment of removal). Arterial cannulas, especially large surgically-placed ones, frequently require surgical repair of the vessel — you do not just pull an arterial cannula and press. On a patient who is still anticoagulated, bleeding is the dominant early risk, so anticoagulation timing around decannulation is planned.

The cannulated limb needs close vascular checks after VA decannulation. A large femoral arterial cannula and its repair can leave the leg at risk for ischemia or a compartment problem. Check distal pulses, color, temperature, capillary refill, sensation, and pain in the affected limb frequently after removal, and escalate any sign of a cold, pulseless, or increasingly painful leg immediately.

What the nurse owns after decannulation

The work does not stop when the circuit is gone. You are watching the cannulation sites for bleeding and hematoma, doing frequent distal limb perfusion checks after arterial decannulation, monitoring for venous thromboembolism (the large cannula sites are a DVT risk), watching hemodynamics and gas exchange now that the safety net is gone, and staying alert for infection at the old sites. There is also often a fluid and diuresis phase as the patient mobilizes third-spaced fluid. The first hours off ECMO are a surveillance-heavy period, not a victory lap.

Bottom line: VV weans by turning the sweep off and testing the lungs; VA weans by reducing flow and testing the heart with echo. Decannulation is a real procedure — venous sites get pressure and air precautions, arterial sites often get surgical repair — and the anticoagulated patient's biggest early risks are bleeding and limb ischemia. The nurse runs the trial, reads the response, and owns the site-and-limb surveillance afterward.

Where to go from here

Complete the set with the ECMO basics guide, the VV vs VA management guide, the circuit troubleshooting and emergencies guide, and the anticoagulation and monitoring guide. For the ventilator-liberation mindset that parallels VV weaning, see the ventilator weaning and SBT guide.

Get The ICU Notebook Newsletter

Clinical tools and career insights for ICU nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.